IDF supports statements at the 154th WHO Executive Board

29 January 2024

The World Health Organization (WHO) held its 154th Executive Board (EB) in Geneva on 22-27 January 2024. The WHO Executive Board advises and facilitates the work of the World Health Assembly, WHO’s decision-making body.  IDF has official relations with WHO and collaborates closely on diabetes awareness, prevention and care. 

Several EB agenda items were particularly relevant for the diabetes community, including universal health coverage and humanitarian emergencies. IDF attended the WHO EB meeting and supported the following EB Constituency Statements: 

  • Agenda item 6: Universal Health Coverage.  
  • Agenda item 7: Follow-up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases. 
  • Agenda item 14: WHO’s work in health emergencies. 

Download the statements at the links below: 


WHO EB154 Constituency Statement: Universal Health Coverage

Statement highlighting the need to prioritise essential circulatory health services in UHC benefit packages to protect individuals and households from catastrophic out-of-pocket expenses.
EB154 - GCCH Constituency Statement on UHC pdf 193KB

WHO EB154 Constituency Statement: follow-up on the prevention and control of NCDs

Statement highlighting the need for more political commitment, policy coherence and resources to address the NCD pandemic.
EB154 - Constituency Statement on HLM on NCDs pdf 330KB

WHO EB154 Constituency Statement: WHO’s work in health emergencies

Statement urging Member States to recognise people living with NCDs as a vulnerable population across WHO's work in health emergencies.
EB154 - Constituency statement on WHO work on health emergencies pdf 292KB

Keep up to date with all the work we’re doing